Martin H Kroll
Overview
Explore the profile of Martin H Kroll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapoor H, Bi C, Kroll M, Salm A, Dominguez E
Microbiol Spectr
. 2024 May;
12(6):e0357523.
PMID: 38709030
Transplant patients are at risk of infections due to long-term immunosuppression contributing to morbidity and mortality in this population. Post-transplant testing guidelines were established to monitor and guide therapeutic interventions...
2.
Kroll M, Bi C, Salm A, Szymanski J, Goldstein D, Wolgast L, et al.
Arch Pathol Lab Med
. 2023 Jun;
147(10):1109-1118.
PMID: 37338199
Context.—: Disease courses in COVID-19 patients vary widely. Prediction of disease severity on initial diagnosis would aid appropriate therapy, but few studies include data from initial diagnosis. Objective.—: To develop...
3.
Pratt G, Bi C, Kroll M, Rao L
Clin Chim Acta
. 2022 Apr;
531:243-247.
PMID: 35447144
Introduction: HbA1c is the gold standard for measuring long-range glycemic control in patients with type-2 diabetes mellitus. Conditions such as CKD or LD can lead to spurious HbA1c test results....
4.
Rao L, Pratt G, Bi C, Kroll M
Clin Chim Acta
. 2022 Feb;
529:21-24.
PMID: 35167841
Introduction: HbA1c is a reliable biomarker for diagnosing and prognosis of diabetes, but many clinical scenarios and interfering factors can affect the test results. Any conditions that affect red cell...
5.
Hilborne L, Bi C, Radcliff J, Kroll M, Kaufman H
Am J Clin Pathol
. 2021 Aug;
157(1):1-4.
PMID: 34463337
Objectives: Given the long-term consequences of untreated diabetes, patients benefit from timely diagnoses. Payer policies often recognize glucose but not hemoglobin A1c (HbA1c) for diabetes screening. This study evaluates the...
6.
Bi C, Clark R, Master R, Kapoor H, Kroll M, Salm A, et al.
Microbiol Spectr
. 2021 Jul;
9(1):e0009621.
PMID: 34319139
Both the QuantiFERON-TB Gold Plus (QFT-Plus) and the QuantiFERON-TB Gold In-Tube (QFT-GIT) tests are interferon gamma (IFN-γ) release assays (IGRAs) intended to detect cell-mediated immune responses to Mycobacterium tuberculosis antigens....
7.
Srisawasdi P, Rodcharoen P, Vanavanan S, Chittamma A, Sukasem C, Na Nakorn C, et al.
Pharmgenomics Pers Med
. 2021 Jan;
14:1-13.
PMID: 33447072
Objective: Patients treated with statins for dyslipidemia may still have a residual risk of atherosclerotic cardiovascular disease (ASCVD). To determine whether genetic variants in the cholesteryl ester transport protein (CETP),...
8.
Kaufman H, Niles J, Kroll M, Bi C, Holick M
PLoS One
. 2020 Sep;
15(9):e0239252.
PMID: 32941512
Until treatment and vaccine for coronavirus disease-2019 (COVID-19) becomes widely available, other methods of reducing infection rates should be explored. This study used a retrospective, observational analysis of deidentified tests...
9.
Puangpetch A, Srisawasdi P, Unaharassamee W, Jiratjintana N, Vanavanan S, Punprasit S, et al.
Pharmgenomics Pers Med
. 2019 Sep;
12:155-166.
PMID: 31496784
Objective: To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter () rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C...
10.
Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll M
Diabetes Metab Syndr Obes
. 2018 Jun;
11:241-253.
PMID: 29910627
Background: Body mass index (BMI) and percentage of body fat (PBF) are used to measure obesity; however, their performance in identifying cardiometabolic risk in Southeast Asians is unclear. Generally, Asian...